Literature DB >> 2899585

Gastrointestinal carriage rate of Clostridium difficile in elderly, chronic care hospital patients.

C Cefai1, T S Elliott, K W Woodhouse.   

Abstract

The carriage rate of Clostridium difficile in patients at a chronic care hospital was determined by two point prevalence surveys at 6-monthly intervals. In the first survey C. difficile or its toxin was present in stool samples from five symptomless patients on three of the four wards studied. All of these colonized patients had been in hospital for at least 2 months, but there was no relationship between carriage of the organism and antibiotic use. When the survey was repeated 6 months later, no symptomless carriers were found but one symptomatic patient had C. difficile and its toxin present in the stool. The results suggest that C. difficile should always be considered as a possible cause of diarrhoea in long-stay hospitalized patients.

Entities:  

Mesh:

Year:  1988        PMID: 2899585     DOI: 10.1016/0195-6701(88)90086-2

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Diarrhea, clostridium difficile, and intestinal inflammation in residents of a long-term care facility.

Authors:  Laurie Archbald-Pannone; Jesus Emmanuel Sevilleja; Richard Guerrant
Journal:  J Am Med Dir Assoc       Date:  2010-03-15       Impact factor: 4.669

2.  Usefulness of culture in the diagnosis of Clostridium difficile infection.

Authors:  F Bond; G Payne; S P Borriello; H Humphreys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

3.  Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics.

Authors:  J Ryan; C Murphy; C Twomey; R Paul Ross; M C Rea; J MacSharry; B Sheil; F Shanahan
Journal:  Ir J Med Sci       Date:  2009-06-04       Impact factor: 1.568

Review 4.  Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications.

Authors:  Luis Furuya-Kanamori; John Marquess; Laith Yakob; Thomas V Riley; David L Paterson; Niki F Foster; Charlotte A Huber; Archie C A Clements
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.